OpenURL Connection Search

Select item for more details and to access through your institution.

Current prostate cancer screening and treatment strategies may not support a holistic nationwide program.
Published in:
Cancer (0008543X), 2022, v. 128, n. 15, p. 2858, doi. 10.1002/cncr.34337
By:
- Nnate, Daniel A.;
- Ball, Jacquie
Publication type:
Article
Trastuzumab deruxtecan beats trastuzumab emtansine in lowered disease progression, death.
Published in:
2022
Publication type:
journal article
Breast arterial calcification is a risk factor for cardiovascular disease.
Published in:
2022
Publication type:
journal article
Mortality after multivitamin supplementation: Nearly 35‐year follow‐up of the randomized Linxian Dysplasia Nutrition Intervention Trial.
Published in:
Cancer (0008543X), 2022, v. 128, n. 15, p. 2939, doi. 10.1002/cncr.34344
By:
- Fan, Jin‐Hu;
- Wang, Jian‐Bing;
- Yang, Huan;
- Dawsey, Sanford M.;
- Taylor, Philip R.;
- Qiao, You‐Lin;
- Abnet, Christian C.
Publication type:
Article
First person profile: Monica Morrow, MD: The chief of the Breast Service at Memorial Sloan Kettering Cancer Center (MSKCC) has made a lasting impact on breast surgical oncology: The chief of the Breast Service at Memorial Sloan Kettering Cancer Center (MSKCC) has made a lasting impact on breast surgical oncology.
Published in:
2022
Publication type:
journal article
Vitamin D and breast cancer: Stop torturing the data!
Published in:
Cancer (0008543X), 2022, v. 128, n. 15, p. 2999, doi. 10.1002/cncr.34272
Publication type:
Article
Molecular classification in endometrial cancer: Opportunities for precision oncology in a changing landscape.
Published in:
Cancer (0008543X), 2022, v. 128, n. 15, p. 2853, doi. 10.1002/cncr.34328
By:
- Jamieson, Amy;
- Barroilhet, Lisa M.;
- McAlpine, Jessica N.
Publication type:
Article
The yield and effectiveness of breast cancer surveillance in women with PTEN Hamartoma Tumor Syndrome.
Published in:
Cancer (0008543X), 2022, v. 128, n. 15, p. 2883, doi. 10.1002/cncr.34326
By:
- Hoxhaj, Alma;
- Drissen, Meggie M.C.M.;
- Vos, Janet R.;
- Bult, Peter;
- Mann, Ritse M.;
- Hoogerbrugge, Nicoline
Publication type:
Article
Reply to "Vitamin D and breast cancer: Stop torturing the data!".
Published in:
Cancer (0008543X), 2022, v. 128, n. 15, p. 3000, doi. 10.1002/cncr.34274
By:
- O'Brien, Katie M.;
- Sandler, Dale P.
Publication type:
Article
Further refining 2020 ESGO/ESTRO/ESP molecular risk classes in patients with early‐stage endometrial cancer: A propensity score–matched analysis.
Published in:
Cancer (0008543X), 2022, v. 128, n. 15, p. 2898, doi. 10.1002/cncr.34331
By:
- Nero, Camilla;
- Pasciuto, Tina;
- Cappuccio, Serena;
- Corrado, Giacomo;
- Pelligra, Silvia;
- Zannoni, Gian Franco;
- Santoro, Angela;
- Piermattei, Alessia;
- Minucci, Angelo;
- Lorusso, Domenica;
- Fanfani, Francesco;
- Scambia, Giovanni
Publication type:
Article
State legislative trends related to biomarker testing.
Published in:
Cancer (0008543X), 2022, v. 128, n. 15, p. 2865, doi. 10.1002/cncr.34271
By:
- Sadigh, Gelareh;
- Goeckner, Hilary Gee;
- Kazerooni, Ella A.;
- Johnson, Bruce E.;
- Smith, Robert A.;
- Adams, Devon V.;
- Carlos, Ruth C.
Publication type:
Article
First phase 1 clinical study of olaparib in pediatric patients with refractory solid tumors.
Published in:
Cancer (0008543X), 2022, v. 128, n. 15, p. 2949, doi. 10.1002/cncr.34270
By:
- Takagi, Masatoshi;
- Ogawa, Chitose;
- Iehara, Tomoko;
- Aoki‐Nogami, Yuki;
- Ishibashi, Eri;
- Imai, Minoru;
- Kimura, Toshimi;
- Nagata, Masashi;
- Yasuhara, Masato;
- Masutani, Mitsuko;
- Yoshimura, Kenichi;
- Tomizawa, Daisuke;
- Ogawa, Atsushi;
- Yonemori, Kan;
- Morishita, Aoi;
- Miyamoto, Satoshi;
- Takita, Junko;
- Kihara, Tetsuro;
- Nobori, Kiyoshi;
- Hasebe, Kazuhisa
Publication type:
Article
Multidisciplinary integrated care pathway for von Hippel–Lindau disease.
Published in:
Cancer (0008543X), 2022, v. 128, n. 15, p. 2871, doi. 10.1002/cncr.34265
By:
- Wolters, Wendy P. G.;
- Dreijerink, Koen M. A.;
- Giles, Rachel H.;
- van der Horst‐Schrivers, Anouk N. A.;
- van Nesselrooij, Bernadette;
- Zandee, Wouter T.;
- Timmers, Henri J. L. M.;
- Seute, Tatjana;
- de Herder, Wouter W.;
- Verrijn Stuart, Annemarie A.;
- Kilic, Emine;
- Brinkman, Willem M.;
- Zondervan, Patricia J.;
- Vandertop, W. Peter;
- Daniels, Anthony B.;
- Wolbers, Tijmen;
- Links, Thera P.;
- van Leeuwaarde, Rachel S.
Publication type:
Article
First‐line chemotherapy in advanced intra‐abdominal well‐differentiated/dedifferentiated liposarcoma: An EORTC Soft Tissue and Bone Sarcoma Group retrospective analysis.
Published in:
Cancer (0008543X), 2022, v. 128, n. 15, p. 2932, doi. 10.1002/cncr.34264
By:
- Stacchiotti, Silvia;
- Van der Graaf, Winette T. A.;
- Sanfilippo, Roberta G.;
- Marreaud, Sandrine I.;
- Van Houdt, Winan J.;
- Judson, Ian R.;
- Gronchi, Alessandro;
- Gelderblom, Hans;
- Litiere, Saskia;
- Kasper, Bernd
Publication type:
Article
Efficacy of post‐induction therapy for high‐risk neuroblastoma patients with end‐induction residual disease.
Published in:
Cancer (0008543X), 2022, v. 128, n. 15, p. 2967, doi. 10.1002/cncr.34263
By:
- Desai, Ami V.;
- Applebaum, Mark A.;
- Karrison, Theodore G.;
- Oppong, Akosua;
- Yuan, Cindy;
- Berg, Katherine R.;
- MacQuarrie, Kyle;
- Sokol, Elizabeth;
- Hall, Anurekha G.;
- Pinto, Navin;
- Wolfe, Ian;
- Mody, Rajen;
- Shusterman, Suzanne;
- Smith, Valeria;
- Foster, Jennifer H.;
- Nassin, Michele;
- LaBelle, James L.;
- Bagatell, Rochelle;
- Cohn, Susan L.
Publication type:
Article
A bridge over troubled water—Extending induction for high‐risk neuroblastoma patients with poor end‐of‐induction response.
Published in:
Cancer (0008543X), 2022, v. 128, n. 15, p. 2880, doi. 10.1002/cncr.34267
By:
- Federico, Sara M.;
- Cash, Thomas
Publication type:
Article
Reply to "Cancer treatment in the time of COVID‐19 pandemics: A new concern".
Published in:
Cancer (0008543X), 2022, v. 128, n. 15, p. 2992, doi. 10.1002/cncr.34250
By:
- Englum, Brian R.;
- Prasad, Nikhil K.;
- Turner, Douglas J.;
- Sorkin, John D.;
- Lal, Brajesh K.
Publication type:
Article
Circulating tumor and invasive cell expression profiling predicts effective therapy in pancreatic cancer.
Published in:
Cancer (0008543X), 2022, v. 128, n. 15, p. 2958, doi. 10.1002/cncr.34269
By:
- Yu, Kenneth H.;
- Park, Jennifer;
- Mittal, Avni;
- Abou‐Alfa, Ghassan K.;
- El Dika, Imane;
- Epstein, Andrew S.;
- Ilson, David H.;
- Kelsen, David P.;
- Ku, Geoffrey Y.;
- Li, Jia;
- Park, Wungki;
- Varghese, Anna M.;
- Chou, Joanne F‐L;
- Capanu, Marinela;
- Cooper, Brandon;
- Bartlett, Andrew;
- McCarthy, Devan;
- Sangar, Vineet;
- McCarthy, Brian;
- O'Reilly, Eileen M.
Publication type:
Article
Additional cytogenetic features determine outcome in patients allografted for TP53 mutant acute myeloid leukemia.
Published in:
Cancer (0008543X), 2022, v. 128, n. 15, p. 2922, doi. 10.1002/cncr.34268
By:
- Loke, Justin;
- Labopin, Myriam;
- Craddock, Charles;
- Cornelissen, Jan J.;
- Labussière‐Wallet, Hélène;
- Wagner‐Drouet, Eva Maria;
- Van Gorkom, Gwendolyn;
- Schaap, Nicolaas P.M.;
- Kröger, Nicolaus M.;
- Veelken, Joan Hendrik;
- Rovira, Montserrat;
- Menard, Anne Lise;
- Bug, Gesine;
- Bazarbachi, Ali;
- Giebel, Sebastian;
- Brissot, Eolia;
- Nagler, Arnon;
- Esteve, Jordi;
- Mohty, Mohamad
Publication type:
Article
Clinical presentation and outcome of human papillomavirus‐positive nasopharyngeal carcinoma in a North American cohort.
Published in:
Cancer (0008543X), 2022, v. 128, n. 15, p. 2908, doi. 10.1002/cncr.34266
By:
- Huang, Shao Hui;
- Jacinto, J. C. Kennetth;
- O'Sullivan, Brian;
- Su, Jie;
- Kim, John;
- Ringash, Jolie;
- Spreafico, Anna;
- Yu, Eugene;
- Perez‐Ordonez, Bayardo;
- Weinreb, Ilan;
- Cho, John;
- Hope, Andrew J.;
- Bratman, Scott V.;
- Giuliani, Meredith E.;
- Hosni, Ali;
- Hahn, Ezra;
- Goldstein, David P.;
- Tong, Li;
- Eng, Lawson;
- Xu, Wei
Publication type:
Article
Adjuvant immunotherapy in patients with high‐risk muscle‐invasive urothelial carcinoma: The potential impact of informative censoring.
Published in:
Cancer (0008543X), 2022, v. 128, n. 15, p. 2892, doi. 10.1002/cncr.34255
By:
- Martini, Alberto;
- Yu, Menggang;
- Raggi, Daniele;
- Joshi, Himanshu;
- Fallara, Giuseppe;
- Montorsi, Francesco;
- Necchi, Andrea;
- Galsky, Matthew D.
Publication type:
Article
Noncancer comparators in cancer survivorship studies.
Published in:
Cancer (0008543X), 2022, v. 128, n. 15, p. 2994, doi. 10.1002/cncr.34253
By:
- Chubak, Jessica;
- Lund, Jennifer L.
Publication type:
Article
Frailty and risk of mortality in older cancer survivors and adults without a cancer history: Evidence from the National Health and Nutrition Examination Survey, 1999‐2014.
Published in:
Cancer (0008543X), 2022, v. 128, n. 15, p. 2978, doi. 10.1002/cncr.34258
By:
- Zhang, Dongyu;
- Mobley, Erin M.;
- Manini, Todd M.;
- Leeuwenburgh, Christiaan;
- Anton, Stephen D.;
- Washington, Caretia J.;
- Zhou, Daohong;
- Parker, Alexander S.;
- Okunieff, Paul G.;
- Bian, Jiang;
- Guo, Yi;
- Pahor, Marco;
- Hiatt, Robert A.;
- Braithwaite, Dejana
Publication type:
Article
Reply to "Noncancer comparators in cancer survivorship studies".
Published in:
Cancer (0008543X), 2022, v. 128, n. 15, p. 2995, doi. 10.1002/cncr.34254
By:
- Kobayashi, Lindsay C.;
- Westrick, Ashly C.;
- Doshi, Aalap;
- Ellis, Katrina R.;
- Jones, Carly R.;
- LaPensee, Elizabeth;
- Mondul, Alison M.;
- Mullins, Megan A.;
- Wallner, Lauren P.
Publication type:
Article
Cancer treatment in the time of COVID‐19 pandemics: A new concern.
Published in:
Cancer (0008543X), 2022, v. 128, n. 15, p. 2991, doi. 10.1002/cncr.34249
By:
- Nasrollahi, Hamid;
- Molavi Vardanjani, Hossein;
- Pasalar, Mehdi
Publication type:
Article
How should decision aids be developed, and which patient outcomes should be assessed?
Published in:
Cancer (0008543X), 2022, v. 128, n. 15, p. 2988, doi. 10.1002/cncr.34247
By:
- Diefenbach, Michael A.;
- Miller, Suzanne M.
Publication type:
Article
Reply to "How should decision aids be developed, and which patient outcomes should be assessed?".
Published in:
Cancer (0008543X), 2022, v. 128, n. 15, p. 2990, doi. 10.1002/cncr.34246
By:
- Kim, Simon P.;
- Tilburt, Jon C.
Publication type:
Article
Neither tamoxifen nor aromatase inhibitors increase the risk of Parkinson disease in the UK Biobank cohort.
Published in:
Cancer (0008543X), 2022, v. 128, n. 15, p. 2997, doi. 10.1002/cncr.34245
By:
- Lehrer, Steven;
- Rheinstein, Peter H.
Publication type:
Article
Issue Information.
Published in:
Cancer (0008543X), 2022, v. 128, n. 15, p. 2841, doi. 10.1002/cncr.33019
Publication type:
Article

Found: 29